Québec Nickel Corp. Announces Closing of the First Tranche of Its Previously Announced Private Placement
VANCOUVER, British Columbia--(BUSINESS WIRE)--Québec Nickel Corp. (CSE: QNI) (“Québec Nickel Corp.” or the “Company”) is…
3 years ago
Québec Nickel Corp. Announces Closing of the First Tranche of Its Previously Announced Private Placement
VANCOUVER, British Columbia--(BUSINESS WIRE)--Québec Nickel Corp. (CSE: QNI) (“Québec Nickel Corp.” or the “Company”) is…
3 years ago
ONE Championship Welcomes Stage Front VIP as Global VIP Experience Partner
Experiences for ONE’s U.S. Debut in 2023 to be Announced in Near Future SINGAPORE--(BUSINESS WIRE)--ONE…
3 years ago
ONE Championship Welcomes Stage Front VIP as Global VIP Experience Partner
Experiences for ONE’s U.S. Debut in 2023 to be Announced in Near Future SINGAPORE--(BUSINESS WIRE)--ONE…
3 years ago
Looking for a holiday gift? Choose Rokid Air and feel the thrill of carrying a big screen in your pocket
HANGZHOU, China--(BUSINESS WIRE)--The holiday season is back! How do you get your favorite entertainment whenever,…
3 years ago
Datopotamab Deruxtecan Showed Promising Responses as Monotherapy and in Combination with Durvalumab in Patients with Metastatic Triple Negative Breast Cancer in Two Early Trials
Daiichi Sankyo and AstraZeneca’s TROP2 directed ADC showed an encouraging objective response rate of 32%…
3 years ago
Datopotamab Deruxtecan Showed Promising Responses as Monotherapy and in Combination with Durvalumab in Patients with Metastatic Triple Negative Breast Cancer in Two Early Trials
Daiichi Sankyo and AstraZeneca’s TROP2 directed ADC showed an encouraging objective response rate of 32%…
3 years ago
Takeda to Present Data at 64th American Society of Hematology (ASH) Annual Meeting, Demonstrating Commitment to Patients with Hematologic Cancers and Other Blood Diseases
? Company to Feature 15 Company-Sponsored and Nine Collaborative Abstracts in Oncology and Hematology ?…
3 years ago
Azura Ophthalmics Presents Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in Meibomian Gland Dysfunction at Ophthalmology Innovation Summit XII
TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a…
3 years ago
Inside information: Sievi Capital’s target company Nordic Rescue Group’s subsidiary ceases the manufacturing of rescue lifts
Sievi Capital Plc Inside information 9 December 2022 at 2:00 pm EET Inside information: Sievi…
3 years ago